October 5, 2018

Orchard Therapeutics plans $172.5 million U.S. IPO

Orchard Therapeutics is seeking to raise up to $172.5 million from a planned stock offering in the U.S., according to a regulatory filing.

The U.K. biopharmaceutical company, which has yet to post a profit, filed documents for the offering under Orchard RX Ltd. but said it would change its name to Orchard Therapeutics PLC. It plans to apply for its American depositary shares to trade on the Nasdaq under the symbol ORTX.

Read more

Back to News